WeDaita organizes its agents into three stages. Availability is tracked per capability, not just per agent — some capabilities within an agent are live in production while others in the same agent are still in development.
DBRA — Deep Biomedical Research Agents (Stage 1: live)
- Live: Deep Research on drug research; disease-to-target hypothesis generation.
- In development: Drug Target Prioritization; Drug Repurposing.
This is the platform's most mature stage and the recommended starting point for a first task (see Getting Started).
ADDA — Autonomous Drug Design Agents (Stage 2: in development)
- Furthest along, still in development: Protein / antibody drug design.
- In development: Peptide/Macrocycle design; small-molecule design & optimization.
ADDA as a whole is not yet available for general use. Check the platform's ADDA page for the current status of each sub-capability before planning an evaluation around it.
CTIA — Clinical Trial Intelligence Agents (Stage 3: roadmap)
Digital twin trial simulation, predictive patient recruitment, AI-assisted protocol design, and portfolio optimization are roadmap items only — no live capability exists yet in this stage.
For pricing and credit consumption per agent, see Credits & Billing.